Dysmenorrhea
📧 Sign up to get email alerts when something new happens for Dysmenorrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities [NA]
This clinical trial update reports the completion and evaluation of 'Period Kits' for adolescents with intellectual and developmental disabi…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Music for Pain in Primary Dysmenorrhea [NA]
The document reports the completion and posting of results for a clinical trial evaluating music therapy to alleviate pain in primary dysmen…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Effect of Emotional Freedom Technique on Symptoms in Dysmenorrhea [NA]
This clinical trial update reports the completion of a study evaluating the effects of Emotional Freedom Technique on symptoms of dysmenorrh…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Physical Activity Level and Insomnia
Cairo University is conducting a clinical trial to examine the relationship between physical activity levels and insomnia in individuals wit…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Integrated Exercise Approach Strength Postural Stability Menstrual Cycle Biomarkers Eumenorrheic Females [NA]
A clinical trial led by Riphah International University examining an integrated exercise approach to improve strength, postural stability, a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Magnetic Reflexologic Insoles for Primary Dysmenorrhea [NA]
A clinical trial evaluating magnetic reflexologic insoles for primary dysmenorrhea is listed as not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 [Phase 2, Phase 3]
A clinical trial evaluating Cramp Bites for dysmenorrhea in women aged 18-25 has completed Phase 2 and Phase 3.
-
FDA approval · 2024-03-27FDA Approved: PERIOD PILLS BY BIIKAY — Supplemental Application (Kai Squared)
FDA approved a supplemental application for PERIOD PILLS BY BIIKAY, a combination of acetaminophen and ibuprofen, intended for menstrual per…
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea [Phase 3]
Phase 3 clinical trial evaluating DEH113 for efficacy and safety in treating menstrual cramp pain due to primary dysmenorrhea; status not ye…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: The Effectivenes of Non-invasive Neuromodulation in Adult Women With Primary Dysmenorrhea, Through the TENS Stimulation at Different Times of Mentrual Cycle in Each Group [Phase 3]
Phase 3 clinical trial evaluating non-invasive neuromodulation (TENS) in adult women with primary dysmenorrhea; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain [Phase 4]
A Phase 4 clinical trial evaluating improved NSAID management for dysmenorrhea and bladder pain has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Dark Chocolate, Coconut Water, and Ibuprofen in Managing Primary Dysmenorrhea [Phase 2]
A Phase 2 clinical trial evaluating dark chocolate, coconut water, and ibuprofen for managing primary dysmenorrhea has completed.
-
FDA approval · 2023-07-13FDA Approved: PERIOD PILLS BY BIIKAY — Original Application (Kai Squared)
FDA approved PERIOD PILLS BY BIIKAY, a combination product of acetaminophen and ibuprofen, under Kai Squared's Original Application for reli…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Chronic Pain Risk Associated With Menstrual Period Pain [Phase 4]
Phase 4 clinical trial update examining chronic pain risk associated with menstrual period pain has completed and results posted.
-
FDA approval · 2023-05-05FDA Approved: IBUPROFEN — Supplemental Application (Winco Foods, LLC)
The FDA approved a supplemental application for a generic ibuprofen product developed by Winco Foods, LLC.
-
FDA approval · 2022-11-15FDA Approved: CAREONE IBUPROFEN — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE IBUPROFEN (ibuprofen) filed by American Sales Company under ANDA077349.
-
FDA approval · 2022-10-06FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s Naproxen and Esomeprazole Magnesium as an Original Application (ANDA213699), providing a generic versi…
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
FDA approval · 2022-06-07FDA Approved: NAPROXEN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber's naproxen generic original application for Naproxen. This generic NSAID is approved for relief of pain and inflammation…
-
FDA approval · 2022-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Apotex Corp.)
FDA approved Apotex Corp's original application for diclofenac sodium tablets, a generic NSAID. This approval enables Apotex to market a gen…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Effect of Melatonin on Reduction of Pelvic Pain [Phase 2]
Phase 2 clinical trial evaluating melatonin for reduction of pelvic pain in dysmenorrhea and endometriosis completed.
-
FDA approval · 2022-03-11FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application for naproxen sodium granules from Granules India Ltd, resulting in an approved supplemental request …
-
FDA approval · 2022-03-09FDA Approved: CELECOXIB — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Celecoxib from Micro Labs Limited under an ANDA.
-
FDA approval · 2022-01-11FDA Approved: CELECOXIB — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)
The FDA approved a supplemental application for Celecoxib submitted by NIVAGEN Pharmaceuticals, Inc., for a generic Celecoxib product.
-
FDA approval · 2022-01-05FDA Approved: CELECOXIB — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic celecoxib product (Celecoxib) under ANDA 202240.